Although BRAF (V600E) exists only in ~ 7% of all cancers, it is highly prevalent in some tissue-specific cancers such as melanoma (50~60%), thyroid cancer (40~50%), and histiocytosis (~50%) [78–81], albeit the underlying molecular mechanism(s) remains unknown. This evidence concerns the gene BRAF and cancer.